Hemorrhagic disease of the newborn: modern approaches to diagnosis, prevention and treatment

Background. Hemorrhagic disease of the newborn is a pathological condition in newborns and children during the first months of life, caused by vitamin K deficiency of dependent blood coagulation factors and manifested by increased bleeding. The incidence of hemorrhagic disease of the newborn varies...

Full description

Saved in:
Bibliographic Details
Main Authors: E. M. Rashkova, A. A. Shakirova, H. A. Sarkisyan, L. A. Levchenko, S. V. Cherkasova, E. I. Shabelnikova
Format: Article
Language:Russian
Published: Open Systems Publication 2023-10-01
Series:Лечащий Врач
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/1119
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849404013173276672
author E. M. Rashkova
A. A. Shakirova
H. A. Sarkisyan
L. A. Levchenko
S. V. Cherkasova
E. I. Shabelnikova
author_facet E. M. Rashkova
A. A. Shakirova
H. A. Sarkisyan
L. A. Levchenko
S. V. Cherkasova
E. I. Shabelnikova
author_sort E. M. Rashkova
collection DOAJ
description Background. Hemorrhagic disease of the newborn is a pathological condition in newborns and children during the first months of life, caused by vitamin K deficiency of dependent blood coagulation factors and manifested by increased bleeding. The incidence of hemorrhagic disease of the newborn varies in different regions of the world, in Russia, according to the literature data, it ranges from 0.25 to 1.7%. Hemorrhagic disease of the newborn is characterized by the development of bleeding and hemorrhage, which negatively affect the function and further development of a number of organs and systems of the child, especially the central nervous system and the gastrointestinal tract. Based on the etiology of the development of the disease described above, HDN is classified into primary (idiopathic) and secondary. Depending on the age of onset, early is distinguished – it manifests itself in the first 24 hours of life, classical – develops on the 2-7th day and late, manifesting itself after 1 week of life (rarely occurs at the age of up to 6 months of life, and some authors indicate the age children under 1 year of age) hemorrhagic disease of the newborn forms. The key priority of neonatologists is to single out from the number of born children, newborns who are at risk for HRD for the purpose of prophylactic administration of vitamin K to them, which will prevent severe undesirable consequences of the disease. A genetic study using logistic regression analysis confirmed a higher risk of intraventricular hemorrhages in newborns with polymorphisms in the VKORC1 genes, which is responsible for the binding of vitamin K1 to cysteine, and thus for a decrease in its concentration in carriers of this gene. Despite the variability in approaches to doses, methods and timing of administration, parenteral administration of vitamin K is the only reliable and preferred way to prevent this disease. In the case of the development of hemorrhagic disease of the newborn, modern approaches to the diagnosis and treatment of this pathology have been developed.Results. The article presents modern approaches to the prevention, diagnosis and therapy of vitamin K-dependent hemorrhagic disease of the newborn.
format Article
id doaj-art-9adf56466967423383ded73f2ef8d37d
institution Kabale University
issn 1560-5175
2687-1181
language Russian
publishDate 2023-10-01
publisher Open Systems Publication
record_format Article
series Лечащий Врач
spelling doaj-art-9adf56466967423383ded73f2ef8d37d2025-08-20T03:37:06ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812023-10-0109576310.51793/OS.2023.26.9.0071112Hemorrhagic disease of the newborn: modern approaches to diagnosis, prevention and treatmentE. M. Rashkova0A. A. Shakirova1H. A. Sarkisyan2L. A. Levchenko3S. V. Cherkasova4E. I. Shabelnikova5Federal State Autonomous Educational Institution of Higher Education N. I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian FederationFederal State Autonomous Educational Institution of Higher Education N. I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian FederationFederal State Autonomous Educational Institution of Higher Education N. I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian FederationFederal State Autonomous Educational Institution of Higher Education N. I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian FederationFederal State Autonomous Educational Institution of Higher Education N. I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation ; State Budgetary Healthcare Institution of the City of Moscow Filatov N. F. Children's City Hospital of the Department of Health of the City of MoscowFederal State Autonomous Educational Institution of Higher Education N. I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian FederationBackground. Hemorrhagic disease of the newborn is a pathological condition in newborns and children during the first months of life, caused by vitamin K deficiency of dependent blood coagulation factors and manifested by increased bleeding. The incidence of hemorrhagic disease of the newborn varies in different regions of the world, in Russia, according to the literature data, it ranges from 0.25 to 1.7%. Hemorrhagic disease of the newborn is characterized by the development of bleeding and hemorrhage, which negatively affect the function and further development of a number of organs and systems of the child, especially the central nervous system and the gastrointestinal tract. Based on the etiology of the development of the disease described above, HDN is classified into primary (idiopathic) and secondary. Depending on the age of onset, early is distinguished – it manifests itself in the first 24 hours of life, classical – develops on the 2-7th day and late, manifesting itself after 1 week of life (rarely occurs at the age of up to 6 months of life, and some authors indicate the age children under 1 year of age) hemorrhagic disease of the newborn forms. The key priority of neonatologists is to single out from the number of born children, newborns who are at risk for HRD for the purpose of prophylactic administration of vitamin K to them, which will prevent severe undesirable consequences of the disease. A genetic study using logistic regression analysis confirmed a higher risk of intraventricular hemorrhages in newborns with polymorphisms in the VKORC1 genes, which is responsible for the binding of vitamin K1 to cysteine, and thus for a decrease in its concentration in carriers of this gene. Despite the variability in approaches to doses, methods and timing of administration, parenteral administration of vitamin K is the only reliable and preferred way to prevent this disease. In the case of the development of hemorrhagic disease of the newborn, modern approaches to the diagnosis and treatment of this pathology have been developed.Results. The article presents modern approaches to the prevention, diagnosis and therapy of vitamin K-dependent hemorrhagic disease of the newborn.https://journal.lvrach.ru/jour/article/view/1119vitamin khemorrhagic disease of newbornshemorrhagic syndrome
spellingShingle E. M. Rashkova
A. A. Shakirova
H. A. Sarkisyan
L. A. Levchenko
S. V. Cherkasova
E. I. Shabelnikova
Hemorrhagic disease of the newborn: modern approaches to diagnosis, prevention and treatment
Лечащий Врач
vitamin k
hemorrhagic disease of newborns
hemorrhagic syndrome
title Hemorrhagic disease of the newborn: modern approaches to diagnosis, prevention and treatment
title_full Hemorrhagic disease of the newborn: modern approaches to diagnosis, prevention and treatment
title_fullStr Hemorrhagic disease of the newborn: modern approaches to diagnosis, prevention and treatment
title_full_unstemmed Hemorrhagic disease of the newborn: modern approaches to diagnosis, prevention and treatment
title_short Hemorrhagic disease of the newborn: modern approaches to diagnosis, prevention and treatment
title_sort hemorrhagic disease of the newborn modern approaches to diagnosis prevention and treatment
topic vitamin k
hemorrhagic disease of newborns
hemorrhagic syndrome
url https://journal.lvrach.ru/jour/article/view/1119
work_keys_str_mv AT emrashkova hemorrhagicdiseaseofthenewbornmodernapproachestodiagnosispreventionandtreatment
AT aashakirova hemorrhagicdiseaseofthenewbornmodernapproachestodiagnosispreventionandtreatment
AT hasarkisyan hemorrhagicdiseaseofthenewbornmodernapproachestodiagnosispreventionandtreatment
AT lalevchenko hemorrhagicdiseaseofthenewbornmodernapproachestodiagnosispreventionandtreatment
AT svcherkasova hemorrhagicdiseaseofthenewbornmodernapproachestodiagnosispreventionandtreatment
AT eishabelnikova hemorrhagicdiseaseofthenewbornmodernapproachestodiagnosispreventionandtreatment